Skip to main content
Clinical Trials/NCT02969447
NCT02969447CompletedPhase 4

Effect of Intra-venous Oxytocin Injection After Fetal Expulsion in Management of Third-stage of Labor After Second Trimester Medical Pregnancy Termination

University Hospital, Bordeaux2 sites in 1 country27 target enrollmentStarted: October 20, 2016Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 4
Status
Completed
Sponsor
Enrollment
27
Locations
2
Primary Endpoint
Incidence of placental retention

Study Overview

Brief Summary

Prospective randomized trail which compare 2 regimens for third-stage management after second trimester medical pregnancy termination : 10UI intra venous oxytocin or no additional medication after fetal expulsion. Primary outcome was the incidence of placental retention.

Detailed Description

Complication of third stage of labor in second trimester medical pregnancy termination is not well studied. Accord to publications, the placental retention rate is 30 to 40% in these situations. Placental retention may be associated with increased blood loss, increased requirement for blood transfusion anesthetic and operative complications, and infectious morbidity. The high incidence of retained placenta is an area of clinical concern. Publications reveal a wide variation in practices but there are only few studies about third stage of labor in second trimester medical pregnancy termination. The study is a prospective randomized trial. Two third stage management strategies are compared: 10 units of intra venous oxytocin (group 1) and no additional medication (group 2) after fetal expulsion. It concerns pregnancies between 14 and 28 weeks gestation.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • 18 years old and older
  • medical pregnancy termination between 14 and 28 weeks gestation
  • informed consent obtained

Exclusion Criteria

  • less than 18 years old
  • refusal to consent
  • in utero fetal death

Arms & Interventions

Oxytocin administration after fetal expulsion

Experimental

Administration of 10 units of intra venous oxytocin after fetal expulsion

Intervention: Administration of 10 units of intra venous oxytocin after fetal expulsion (Drug)

Outcomes

Primary Outcomes

Incidence of placental retention

Time Frame: Up to 30 minutes after fetal expulsion

Secondary Outcomes

  • Incidence of partial placental retention(Up to 1 hour after fetal expulsion)
  • Incidence of digital exploration(Up to 1 hour after fetal expulsion)
  • Incidence of blunt curettage(Up to 1 hour after fetal expulsion)
  • Incidence of post-partum hemorrhage(Up to 1 hour after fetal expulsion)
  • Blood loss(Up to 1 hour after fetal expulsion)

Investigators

Sponsor
University Hospital, Bordeaux
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials